Sign up for our Weekly Checkup Newsletter
Segment reports · Pharmacy

Pharmacy

M&A valuation multiples for healthcare businesses (revenue and EBITDA multiples)

What you get
  • 93 transactions since 2010, 76 with EBITDA multiples
  • Data updated Nov 19, 2026
  • One Excel workbook, delivered as a download link on checkout and by email
  • Single-use license for your firm's project
  • Price $950, one-time

Need every segment, refreshed weekly? Enterprise subscriptions cover the whole database.

Pharmacy segment report

Secure checkout by Stripe. The download link arrives on the next page and by email.

Pharmacy M&A Valuation Segment Report

Comparable Transactions / Precedent Deals

Excel spreadsheet with Scope Research's pharmacy M&A valuation data and benchmarking tools. Transactions are segmented by type, which include specialty, retail, institutional and compounding pharmacies, as well as pharmacy -related services and infusion therapy.

  • 93 transactions with revenue or EBITDA multiples (since 2010)
  • 76 of these deals have reported EBITDA Multiples
  • Last updated 11/19/2026

Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented.

All transactions included in the Scope Research healthcare M&A valuation database are meticulously researched and sourced. Our internal records include an audit trail of links to the majority of our sources.